The topical analgesic plaster with a market of over 18 billion "rules the king"!

Relying on the advantages of reliable efficacy, convenient use, and low adverse reactions, the domestic market for topical analgesics has shown a steady growth trend
.
According to data from Mi Nei.
com, the market size of external analgesics in 2020 will exceed 18 billion yuan, and it is expected to further expand in 2021
.
Among the TOP5 products of China's public medical institutions, Tide's flurbiprofen gel plaster (Zepusi® Debam®) ranked first, with the highest growth rate and the only chemical drug on the list
.
In addition, flurbiprofen gel plaster (Zepsi® Diabet®) has great potential in the terminal market of physical pharmacies in Chinese cities, and its product ranking has risen rapidly for many years.
It is among all topical analgesics with sales of over 100 million in 2020 The only product with a growth rate of over 40%
.
The market for topical analgesics exceeds 18 billion, and plasters are "the king.
" Pain is a disease with complex mechanisms and needs to be treated.
It has become one of the most common health problems today
.
Statistics show that the overall prevalence of chronic pain in China exceeds 30%
.
It can be seen that the base of chronic pain patients is large, and the market for related drugs is broad
.
At present, the main routes of domestic analgesics include oral, injection and topical application
.
Topical analgesics adopt the high technology of transdermal administration, which directly act on the lesions and can avoid gastrointestinal reactions.
It has the advantages of reliable and reliable curative effect, easy to use and carry, low side effects and good safety.
It is suitable for middle-aged and sedentary people.
Used by white-collar workers and sports people
.
With various advantages, topical analgesics have become a standing choice for family analgesics, promoting the expansion of the relevant drug market
.
According to data from Meinnet.
com, the market size of analgesics (chemical medicines + proprietary Chinese medicines) for external use in China’s urban public hospitals, county-level public hospitals, urban community centers, and township health centers (referred to as Chinese public medical institutions) and Chinese urban entity pharmacies in 2020 Over 18 billion yuan, an increase of about 5% year-on-year, and further expansion is expected in 2021
.
From the perspective of subdivided dosage forms, the main dosage forms of topical analgesics include plasters, topical liquids, solutions, aerosols (including sprays, powder mists), ointments, gels, etc.
, of which plasters are the most commonly used.
It accounts for more than 40%, followed by topical liquids and solutions
.
Source of competition pattern of topical analgesic agents in 2020: Compared with other dosage forms, Meinnet database has the advantages of high transdermal absorption rate, good clinical effect, good air permeability, and less allergic reactions.
It is vulnerable to doctors and patients.
Accept and recognize
.
The TOP5 product is released.
This exclusive product of Tide highlights the TOP5 terminal topical analgesics of China's public medical institutions in 2020.
Source: Mynet.
com.
The competition pattern of the terminal competition of Chinese public medical institutions.
The concentration of external analgesics in the terminal market of China's public medical institutions is relatively high.
High, the total market share of TOP5 products in 2020 is close to 45%.
Except for blood circulation and pain relief cream, the other 4 products are exclusive products, including Beijing Tide’s flurbiprofen gel plaster (Zepusi® Debaan®), Yunnan Baiyao aerosol and Yunnan Baiyao ointment, Qizheng Tibetan medicine pain relief plaster
.
Among the TOP5 products, flurbiprofen gel plaster (Zepusi® Debaan®) ranked first, the only external analgesic for chemical drugs on the list, and the highest growth rate among the five products.
Of
.
In recent years, flurbiprofen gel plaster (Zepsi® Debaan®) has maintained a double-digit growth rate in China’s public medical institutions and rapidly increased its volume.
In 2019, it exceeded 1 billion yuan for the first time and replaced Yunnan at the same time.
Baiyao Ointment has become the best-selling topical analgesic, with sales in the first half of 2021 approaching 1 billion yuan, an increase of 55.
03% over the same period last year
.
Flurbiprofen gel plaster (Zepsi® Debion®) is based on the NSAIDs drug flurbiprofen, which has a strong anti-inflammatory and analgesic effect, and is effective for osteoarthritis, frozen shoulder, tendon and tenosynovitis, and muscle pain.
, Swelling and pain caused by trauma, etc.
can play a very good therapeutic effect
.
The product adopts high-quality non-woven fabric backing, hydrophilic polymer gel matrix and net-like skeleton structure.
It has good air permeability and is not easy to allergic.
It has a quick onset and long duration.
It is the national "Guidelines for the Use of Common Therapeutics for Athletes" ( The only topical patch in the 2020 edition, and it has also been recommended by the "Chinese Osteoarthritis Treatment Guidelines" (2021 edition) as the first-line treatment for topical non-steroidal anti-inflammatory drugs (recommendation level: strong recommendation; evidence level: A )
.
TOP5 products for topical analgesics in physical pharmacies in Chinese cities in 2020.
Source: Meine.
com.
Competitive pattern of physical pharmacies in cities in China.
In 2020, physical pharmacies in Chinese cities, TOP5 external analgesics products are all proprietary Chinese medicines, of which 3 are exclusive products , It is Qizheng Tibetan Medicine's Xiaotong Plaster, Yunnan Baiyao's Yunnan Baiyao Aerosol and Yunnan Baiyao Ointment
.
Although Beijing Tide's flurbiprofen gel plaster (Zepusi® Derbyan®) has not ranked among the TOP5 products, it has huge market potential.
This product has maintained a double-digit growth rate in recent years and is used for external use.
The ranking of analgesic products has risen from 28th in 2017 to 13th in 2020, and is expected to continue to rise by 2 places to 11th in 2021
.
It is worth mentioning that among all the topical analgesics with sales of more than 100 million yuan in physical pharmacies in Chinese cities in 2020, flurbiprofen gel plaster (Zepsi® Debion®) has the highest sales growth rate, and it is also the only A product with a growth rate of more than 40%
.
Source: Mi Nei.
com database Note: Mi Nei.
com China's urban entity pharmacy terminal competition pattern database is an enlarged version of urban entity pharmacies that covers 293 prefectures and above cities across the country (excluding county and rural entity pharmacies), and continuously monitors all categories Database
.
The above sales are calculated based on the average retail price of the product at the terminal
.